US pharmaceutical stocks plummet, has the market overreacted to Little Kennedy?
Source: Analysis from Wall Street News states that even if Kennedy is confirmed as the Secretary of Health in the usa, he may not be able to "make a big impact". First, there may be divisions within Trump's team; secondly, it is uncertain whether Kennedy has the authority to appoint leaders of departments like the FDA; finally, Trump may appoint individuals with industry backgrounds as FDA commissioners, directing Kennedy's attention to focus on nutrition rather than pharmaceutical approvals. The famous "anti-vaccine pioneer" and advocate for healthy eating, the new government-nominated Secretary of Health Robert Kennedy, is dining with the loyal "fast food enthusiast" Trump, who promotes rapid vaccine development.
DexCom Pairs Its Glucose Monitor With Oura's Smart Ring -- Barrons.com
Express News | DuoRui Pharmaceutical: Sodium Bicarbonate Injection Accepted for Pharmaceutical Registration.
Abbott Unveils New Recommendations and Partnerships to Improve Diversity in Clinical Trials
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Express News | Abbott -Late-Breaking Data Reinforce Long-Term Benefits of Abbott's Amplatzer Amulet Device for People With Atrial Fibrillation at Risk of Stroke